Sprint and T-Mobile have announced an agreement to extend the deadline for their proposed US$26 billion merger deal to July 29, reported Reuters.
The extension was revealed in a filing with the Securities and Exchange Commission, and means that the two carriers now have more time to get the proposed merger approved by both the Federal Communications Commission and the US Department of Justice.
The Justice Department’s Antitrust Division has been exploring whether the deal would result in a major threat to competition. Earlier this month, Justice Department staff members reportedly told Sprint and T-Mobile that their planned merger is unlikely to be approved as it is currently structured.
However, in an interview on CNBC, Justice Department Antitrust Division chief Makan Delrahim said he had not made a decision regarding the T-Mobile and Sprint merger and is waiting for more information from the two companies.
“I have not made up my mind,” he told CNBC. “The investigation continues. We’ve requested some data from the companies that will be forthcoming. We don’t have a set number of meetings or a time-line.”
“If the case is there for us to challenge a transaction or suggest changes, we will do that,” he said. The Division is reviewing the argument that the deal would allow the combined company to produce a better, faster 5G, the next generation of wireless, he added.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas